Prevalence and severity of akathisia in patients on clozapine

Clozapine for the Treatment-Resistant Schizophrenic

1988 • 4,030 citations

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1976 • 2,224 citations

Goodman and Gilman's the pharmacologic basis of therapeutics

1991 • 586 citations

Why Do Schizophrenic Patients Refuse to Take Their Drugs?

1974 • 584 citations

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

1980 • 543 citations

Antipsychotic Drugs, Neurotransmitters, and Schizophrenia

1978 • 500 citations

The Risks and Benefits of Clozapine versus Chlorpromazine

1987 • 299 citations

Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro

1984 • 224 citations

Akathisia With Haloperidol and Thiothixene

1984 • 161 citations

Neuroleptic-induced akathisia: a review

1989 • 135 citations

Phenothiazine-Induced Decompensation

1974 • 131 citations

In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: Implications for drug mechanisms of action

1986 • 128 citations

Who Should Receive Clozapine?

1988 • 91 citations

Clinical Evaluation of Sulpiride in Schizophrenic Patients ‐ A Double‐blind Comparison with Chlorpromazine

1984 • 78 citations

Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain

1984 • 74 citations

Adrenoreceptors and the pharmacology of affective illness: A unifying theory

1987 • 39 citations

Treatment of Akathisia with Lorazepam An Open Clinical Trial

1987 • 37 citations

Sulpiride versus Haloperidol, a Clinical Trial in Schizophrenia. A preliminary report

1984 • 22 citations